Mackie Research analyst André Uddin maintains that oncology-focused immunotherapy company Medicenna (Medicenna Stock Quote, Chart, News TSX:MDNA) … [Read more...] about Medicenna is “highly undervalued”, says Mackie Research
Life Sciences
Content brought to you by:
The Cantech Letter Life Sciences section is brought to you by Relay Medical Corp. (CSNX:RELA). Relay is in the business of commercializing innovative technologies, protected by issued and pending patents, in the medical diagnostics and research field with an emphasis on In Vitro Diagnostics (IVD) and Point of Care Testing (POCT). Click on the logo for more info...
Paradigm Capital launches coverage of Spectral Medical with a “Buy”
Microcap Spectral Medical (Spectral Medical Stock Quote, Chart, News TSX:EDT) got the spotlight in a coverage initiation by Paradigm Capital on … [Read more...] about Paradigm Capital launches coverage of Spectral Medical with a “Buy”
Aurinia Pharmaceuticals is a biopharma stock you should own, Mackie says
All eyes are on Aurinia Pharmaceuticals (Aurinia Pharmaceuticals Stock Quote, Chart, News NASDAQ:AUPH), which just announced the start of a patient … [Read more...] about Aurinia Pharmaceuticals is a biopharma stock you should own, Mackie says
Knight Therapeutics upgraded to “Buy” at Mackie Research
Knight Therapeutics (Knight Therapeutics Stock Quote, Chart, News TSX:GUD) is still in the early innings of its growth trajectory, says Mackie … [Read more...] about Knight Therapeutics upgraded to “Buy” at Mackie Research
Burcon NutraScience is still undervalued, Beacon says
With more fast food chains jumping on the plant protein bandwagon, Beacon Securities analyst Spencer Churchill is liking the opportunity landscape for … [Read more...] about Burcon NutraScience is still undervalued, Beacon says
Knight Therapeutics Grupo Biotoscana acquisition is “transformational”, says GMP
The massive new acquisition of Grupo Biotoscana by Knight Therapeutics (Knight Therapeutics Stock Quote, Chart TSX:GUD) is a huge positive, says GMP … [Read more...] about Knight Therapeutics Grupo Biotoscana acquisition is “transformational”, says GMP
Medicenna Therapeutics has an upside of 187 per cent, Mackie says
After recent news from clinical-stage biotech company Medicenna Therapeutics (Medicenna Therapeutics Stock Quote, Chart, News TSX:MDNA), Mackie … [Read more...] about Medicenna Therapeutics has an upside of 187 per cent, Mackie says
Profound Medical Corp is ready for the big time, says Raymond James
Profound Medical Corp (Profound Medical Corp Stock Quote, Chart, News TSX:PRN) is primed and ready, says Rahul Sarugaser, analyst for Raymond … [Read more...] about Profound Medical Corp is ready for the big time, says Raymond James
Theratechnologies gets price target cut at Mackie Research
Mixed results from the company’s latest earnings has Mackie Research Capital Corporation analyst André Uddin maintaining his “Hold” recommendation for … [Read more...] about Theratechnologies gets price target cut at Mackie Research
It’s time to sell Arbutus Biopharma, says Echelon Wealth
Echelon Wealth Partners analyst Douglas Loe is changing his rating on drug developer Arbutus Biopharma (Arbutus Biopharma Stock Quote, Chart … [Read more...] about It’s time to sell Arbutus Biopharma, says Echelon Wealth
